Combination treatment with tamsulosin and dutasteride for benign prostatic hyperplasia

By Elterman Dean S   Chughtai Bilal   Kaplan Steven A   Barkin Jack  

Aging Health, Vol. 8, Iss. 6, 2012-12 ,pp. : 555-565

Future Medicine

Access to resources Recommend Favorite

Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS)

By Kaplan Steven A.  

The Aging Male, Vol. 16, Iss. 2, 2013-06 ,pp. : 48-51

Informa Healthcare

Access to resources Recommend Favorite

Silodosin: an orally active selective αα₁-adrenoceptor antagonist for benign prostatic hyperplasia

By Guay David RP  

Aging Health, Vol. 5, Iss. 4, 2009-08 ,pp. : 459-473

Future Medicine

Access to resources Recommend Favorite

Male aging: hormonal profiles in serum and urine among patients with benign prostatic hyperplasia versus healthy men

By Basiewicz A.   Mędraś M.   Jankowska E. A.   Hojniak M.  

The Aging Male, Vol. 4, Iss. 3, 2001-09 ,pp. : 134-139

Informa Healthcare

Access to resources Recommend Favorite

Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients

By Aktas Binhan Kagan   Gokkaya Cevdet Serkan   Bulut Suleyman   Dinek Mehmet   Ozden Cuneyt   Memis Ali  

The Aging Male, Vol. 14, Iss. 1, 2011-03 ,pp. : 48-52

Informa Healthcare

Access to resources Recommend Favorite